EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors

Pietro Merli iD, Pietro Crivello iD, Luisa Strocchio iD, Rita Maria Pinto, Mattia Algeri, Francesca Del Bufalo, Daria Pagliara, Marco Becilli, Roberto Carta, Stefania Gaspari iD, Federica Galaverna, Francesco Quagliarella und 7 weitere

British Journal of Haematology · 2023-03 · 200 (5) · 622-632

DOI: 10.1111/bjh.18561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 16.11.2022. Verfasst von Pietro Merli und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Neoplasms, Graft vs Host Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Knochermarkspenderdatei, Joseph-Senker Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High genetic heterogeneity in the human leukocyte antigen (HLA) increases the likelihood of efficient immune response to pathogens and tumours. As measure of HLA diversity, HLA evolutionary divergence (HED) has been shown to predict the response of tumours to immunotherapy and haematopoietic stem cell transplantation (HSCT) in adults. We retrospectively investigated the association of HED with outcomes of 153 paediatric/young adults patients, treated for malignant disorders with HSCT from 9–10/10 HLA‐matched unrelated donors. HED was calculated as pairwise genetic distance between alleles in patient HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQB1 and ‐DPB1, using the locus median to stratify patients with ‘high’ or ‘low’ HED. Patients with high HED‐B and ‐DRB1 showed significantly improved disease‐free survival (DFS), especially when combined (70.8% vs 53.7% p = 0.008). High HED‐B + ‐DRB1 was also associated with improved overall survival (OS) (82.1 vs 66.4% p = 0.014), and concomitant reduction of non‐relapse‐mortality (5.1% vs 21.1% p = 0.006). The impact on OS and DFS of combined HED‐B + ‐DRB1 was confirmed in multivariate analysis [hazard ratio (HR) 0.39, p = 0.009; and HR 0.45, p = 0.007 respectively]. Only high HED scores for HLA‐DPB1 were associated, in univariate analysis, with reduced incidence of relapse (15.9% vs 31.1%, p = 0.03). These results support HED as prognostic marker in allogeneic HSCT and, if confirmed in larger cohorts, would allow its use to inform clinical risk and potentially influence clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationNeoplasmsGraft vs Host DiseaseHumansChildYoung AdultUnrelated DonorsRetrospective StudiesHistocompatibility Testing

Stichwörter der Autor:innen

haematopoietic stem cell transplantationhuman leukocyte antigen (HLA)HLA evolut…

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.
  • Laboratory of Transplant Immunogenetics, Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • German Cancer Consortium, Partner Site Essen/Düsseldorf, Heidelberg, Germany.
  • Catholic University of the Sacred Heart, Department of Life Sciences and Public Health, Rome, Italy.

ORCID-Profile: Pietro Merli, Pietro Crivello, Luisa Strocchio, Stefania Gaspari, Katharina Fleischhauer, Marco Andreani, Franco Locatelli

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsche Knochermarkspenderdatei
  • Joseph-Senker Stiftung
  • Ministero della Salute
  • Deutsche José Carreras Leukämie Stiftung

Zitieren

APA

Merli, P., Crivello, P., Strocchio, L., Pinto, R. M., Algeri, M., Del Bufalo, F., Pagliara, D., Becilli, M., Carta, R., Gaspari, S., Galaverna, F., Quagliarella, F., Boz, G., Catanoso, M. L., Boccieri, E., Troiano, M., Fleischhauer, K., Andreani, M., & Locatelli, F. (2023). Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors. British Journal of Haematology, 200(5), 622-632. https://doi.org/10.1111/bjh.18561

Vancouver

Merli P, Crivello P, Strocchio L, Pinto RM, Algeri M, Del Bufalo F, et al. Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors. British Journal of Haematology. 2023;200(5):622-632. doi:10.1111/bjh.18561

BibTeX
@article{Merli2023,
  author = {Merli, Pietro and Crivello, Pietro and Strocchio, Luisa and Pinto, Rita Maria and Algeri, Mattia and Del Bufalo, Francesca and Pagliara, Daria and Becilli, Marco and Carta, Roberto and Gaspari, Stefania and Galaverna, Federica and Quagliarella, Francesco and Boz, Giulia and Catanoso, Maria Luigia and Boccieri, Emilia and Troiano, Maria and Fleischhauer, Katharina and Andreani, Marco and Locatelli, Franco},
  title = {Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {200},
  number = {5},
  pages = {622--632},
  doi = {10.1111/bjh.18561}
}
Kostenlos starten →